Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05060432
What this trial is testing

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

Who this might be right for
Advanced CancerLung CancerHead and Neck Cancer+1 more
iTeos Belgium SA 153
Testing effectiveness (Phase 2)Study completedNCT02301039
What this trial is testing

SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Sarcoma Alliance for Research through Collaboration 144
Early research (Phase 1)Looking for participantsNCT07391670
What this trial is testing

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab

Who this might be right for
Solid Tumours
AstraZeneca 40
Testing effectiveness (Phase 2)Looking for participantsNCT06281405
What this trial is testing

CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CancerNeoadjuvant Therapy
Fudan University 192
Early research (Phase 1)WithdrawnNCT02357732
What this trial is testing

Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib

Who this might be right for
Metastatic Melanoma
University of Pittsburgh
Not applicableActive Not RecruitingNCT06357806
What this trial is testing

The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients

Who this might be right for
Chronic Hepatitis B
Beijing 302 Hospital 45
Not applicableUnknownNCT03914352
What this trial is testing

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Hospital of Guangxi Medical University 40
Testing effectiveness (Phase 2)Study completedNCT02549209
What this trial is testing

Pembro/Carbo/Taxol in Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Daniela Matei, MD 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110558
What this trial is testing

Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 59
Testing effectiveness (Phase 2)Looking for participantsNCT07555678
What this trial is testing

Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase

Who this might be right for
Anal Squamous Cell Cancer
Fudan University 241
Large-scale testing (Phase 3)UnknownNCT04750083
What this trial is testing

HX008 Plus Chemotherapy VS Pembrolizumab Plus Chemotherapy As the First-line Treatment in Participants With Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Taizhou Hanzhong biomedical co. LTD 700
Testing effectiveness (Phase 2)Study completedNCT02989922
What this trial is testing

Evaluate SHR-1210 in Subjects With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-Resectable
Jiangsu HengRui Medicine Co., Ltd. 220
Testing effectiveness (Phase 2)UnknownNCT03941795
What this trial is testing

Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma

Who this might be right for
Advanced Mucosal Melanoma
Peking University Cancer Hospital & Institute 99
Testing effectiveness (Phase 2)UnknownNCT05149170
What this trial is testing

Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Who this might be right for
Early-stageExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Chinese Academy of Medical Sciences 30
Not applicableLooking for participantsNCT07074470
What this trial is testing

Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL

Who this might be right for
Primary Central Nervous System Lymphoma (PCNSL)
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06944470
What this trial is testing

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Who this might be right for
NSCLC
Shanghai Junshi Bioscience Co., Ltd. 78
Testing effectiveness (Phase 2)Looking for participantsNCT06986785
What this trial is testing

BL-B01D1 Monotherapy, BL-B01D1 in Combination With Lenvatinib, BL-B01D1 in Combination With PD-1 Monoclonal Antibody, and BL-B01D1 in Combination With PD-1 Monoclonal Antibody and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 74
Testing effectiveness (Phase 2)UnknownNCT05139082
What this trial is testing

Study of CDK4/6 Inhibitor Combined With PD-L1 Monoclonal Antibody in the Treatment of PD-1/PD-L1 Resistance and Abnormal Cell Cycle Digestive System Tumors

Who this might be right for
Digestive System Tumors
Peking University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238624
What this trial is testing

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Gene Mutation+1 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT06572813
What this trial is testing

Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
First Affiliated Hospital of Zhejiang University 63
Next Page